Chen Li, Yantao Tian, Yanan Zheng, Fei Yuan, Zheng Shi, Lin Yang, Hao Chen, Lixin Jiang, Xixun Wang, Ping Zhao, Benyan Zhang, Zhenqiang Wang, Qun Zhao, Jianhong Dong, Changhong Lian, Sanrong Xu, Aimin Zhang, Zhichao Zheng, Kang Wang, Chengxue Dang, Dan Wu, Jian Chen, Yingwei Xue, Bo Liang, Xiangdong Cheng, Qian Wang, Luchuan Chen, Tao Xia, Heli Liu, Dazhi Xu, Jing Zhuang, Tao Wu, Xi Zhao, Wei Wu, Hongzhi Wang, Junsheng Peng, Zhiguo Hou, Rongrong Zheng, Yuting Chen, Kai Yin, Zhenggang Zhu. "Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)." Journal of Clinical Oncology, 2025. doi:10.1200/jco.24.00795